123 Main Street, New York, NY 10001
In July 2023, Co-Dx was awarded two grants from the Bill & Melinda Gates Foundation totaling $2.3 million for its tuberculosis (TB) and human papillomavirus (HPV) tests.
The $1.3 million grant for tuberculosis and $987,000 grant for HPV will be applied toward completing the tests for the Co-Dx PCR Home™ platform, which are intended for priority global markets.
Read the article here:
Co-Diagnostics, Inc.
2401 S. Foothill Dr. Suite D
Salt Lake City, UT 84109 USA
1 (801) 438-1036
info@co-dx.com
Co-Dx, Co-Primers, Logix Smart, Co-Dx Box, PCR Home, PCR Pro, and Vector Smart, and unless otherwise specified, all other product and service names appearing in this Internet site are trademarks owned by Co-Diagnostics, Inc., its subsidiaries or affiliates. No use of any Co-Diagnostic trademark, trade name, or trade dress in this site may be made without the prior written authorization of Co-Diagnostics, except to identify the product or services of the company.
TaqMan is a trademark of Roche Molecular Systems.